rs4652673

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001205293.3(CACNA1E):​c.1056-14921G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.685 in 151,916 control chromosomes in the GnomAD database, including 35,741 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.68 ( 35741 hom., cov: 32)

Consequence

CACNA1E
NM_001205293.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.107

Publications

2 publications found
Variant links:
Genes affected
CACNA1E (HGNC:1392): (calcium voltage-gated channel subunit alpha1 E) Voltage-dependent calcium channels are multisubunit complexes consisting of alpha-1, alpha-2, beta, and delta subunits in a 1:1:1:1 ratio. These channels mediate the entry of calcium ions into excitable cells, and are also involved in a variety of calcium-dependent processes, including muscle contraction, hormone or neurotransmitter release, gene expression, cell motility, cell division and cell death. This gene encodes the alpha-1E subunit of the R-type calcium channels, which belong to the 'high-voltage activated' group that maybe involved in the modulation of firing patterns of neurons important for information processing. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. [provided by RefSeq, Apr 2011]
CACNA1E Gene-Disease associations (from GenCC):
  • developmental and epileptic encephalopathy, 69
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Illumina
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • neurodevelopmental disorder
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.768 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CACNA1ENM_001205293.3 linkc.1056-14921G>A intron_variant Intron 7 of 47 ENST00000367573.7 NP_001192222.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CACNA1EENST00000367573.7 linkc.1056-14921G>A intron_variant Intron 7 of 47 1 NM_001205293.3 ENSP00000356545.2
CACNA1EENST00000360108.7 linkc.1056-14921G>A intron_variant Intron 7 of 46 5 ENSP00000353222.3
CACNA1EENST00000367570.6 linkc.1056-14921G>A intron_variant Intron 7 of 46 1 ENSP00000356542.1
CACNA1EENST00000621791.4 linkc.1056-14921G>A intron_variant Intron 7 of 45 1 ENSP00000481619.1
CACNA1EENST00000524607.6 linkc.1491-14921G>A intron_variant Intron 9 of 11 5 ENSP00000432038.2

Frequencies

GnomAD3 genomes
AF:
0.685
AC:
103938
AN:
151798
Hom.:
35713
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.637
Gnomad AMI
AF:
0.827
Gnomad AMR
AF:
0.628
Gnomad ASJ
AF:
0.730
Gnomad EAS
AF:
0.788
Gnomad SAS
AF:
0.654
Gnomad FIN
AF:
0.717
Gnomad MID
AF:
0.658
Gnomad NFE
AF:
0.713
Gnomad OTH
AF:
0.647
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.685
AC:
104010
AN:
151916
Hom.:
35741
Cov.:
32
AF XY:
0.688
AC XY:
51075
AN XY:
74262
show subpopulations
African (AFR)
AF:
0.637
AC:
26360
AN:
41396
American (AMR)
AF:
0.627
AC:
9570
AN:
15260
Ashkenazi Jewish (ASJ)
AF:
0.730
AC:
2534
AN:
3470
East Asian (EAS)
AF:
0.788
AC:
4079
AN:
5176
South Asian (SAS)
AF:
0.655
AC:
3151
AN:
4812
European-Finnish (FIN)
AF:
0.717
AC:
7576
AN:
10570
Middle Eastern (MID)
AF:
0.633
AC:
186
AN:
294
European-Non Finnish (NFE)
AF:
0.713
AC:
48428
AN:
67918
Other (OTH)
AF:
0.651
AC:
1372
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1680
3359
5039
6718
8398
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
820
1640
2460
3280
4100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.698
Hom.:
5615
Bravo
AF:
0.674
Asia WGS
AF:
0.665
AC:
2315
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.90
CADD
Benign
1.7
DANN
Benign
0.71
PhyloP100
0.11
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4652673; hg19: chr1-181665169; API